Onkologie, Hämatologie - Daten und Informationen

Sekundäre ZNS-Lymphome: Literaturreferenzen des Artikels

Autor/en: L. Fischer
Letzte Änderung: 15.08.2006
  • Alvarnas JC, Negrin RS, Horning SJ, Hu WW, Long GD, Schriber JR.
    High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
    Biol Blood Marrow Transplant 2000;6:352-358. PM:10905773

  • Bishop PC, Wilson WH, Pearson D, Janik J, Jaffe ES, Elwood PC.
    CNS involvement in primary mediastinal large B-cell lymphoma.
    J Clin Oncol 1999;17:2479-2485. PM:10561312

  • Blay JY, Conroy T, Chevreau C, Thyss A, Quesnel N, Eghbali H.
    High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
    J Clin Oncol 1998;16:864-871. PM:9508167

  • Bokstein F, Lossos A, Lossos IS, Siegal T.
    Central nervous system relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate combination chemotherapy.
    Leuk Lymphoma 2002;43:587-593. PM:12002763

  • Bollen EL, Brouwer RE, Hamers S, Hermans J, Kluin M, Sankatsing SU.
    Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients.
    Arch Neurol 1997;54:854-859. PM:9236574

  • Bos GM, van Putten WL, van der HB, van den BM, Verdonck LF, Hagenbeek A.
    For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group.
    Ann Oncol 1998;9:191-194. PM:9553665

  • Colocci N, Glantz M, Recht L.
    Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: a review of the literature.
    Semin Neurol 2004;24:395-404. PM:15637651

  • DeAngelis LM.
    Current diagnosis and treatment of leptomeningeal metastasis.
    J Neurooncol 1998;38:245-252. PM:9696379

  • Feugier P, Virion JM, Tilly H, Haioun C, Marit G, Macro M.
    Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.
    Ann Oncol 2004;15:129-133. PM:14679132

  • Finn WG, Peterson LC, James C, Goolsby CL.
    Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry.
    Am J Clin Pathol 1998;110:341-346. PM:9728609

  • Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A.
    Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results.
    Cancer 1998;82:733-739. PM:9477107

  • Glantz MJ, LaFollette S, Jaeckle KA, Shapiro W, Swinnen L, Rozental JR.
    Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.
    J Clin Oncol 1999;17:3110-3116. PM:10506606

  • Gleissner B, Siehl J, Korfel A, Reinhardt R, Thiel E.
    CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.
    Neurology 2002;58:390-396. PM:11839837

  • Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS.
    Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
    J Clin Oncol 1993;11:561-569. PM:8445432

  • Haioun C, Besson C, Lepage E, Thieblemont C, Simon D, Rose C.
    Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte.
    Ann Oncol 2000;11:685-690. PM:10942056

  • Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J.
    World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
    J Clin Oncol 1999;17:3835-3849. PM:10577857

  • Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML.
    A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments].
    Blood 1994;84:1361-1392. PM:8068936

  • Hausdorff J, Davis E, Long G, Hoppe R, van der PM, Lassman C.
    Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
    Cancer J Sci Am 1997;3:303-311. PM:9327155

  • Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM.
    High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.
    Blood 2005;105:496-502. PM:15358629

  • Hiddemann W, Longo DL, Coiffier B, Fisher RI, Cabanillas F, Cavalli F.
    Lymphoma classification--the gap between biology and clinical management is closing.
    Blood 1996;88:4085-4089. PM:8943841

  • Hochman J, Assaf N, Deckert-Schluter M, Wiestler OD, Pe'er J.
    Entry routes of malignant lymphoma into the brain and eyes in a mouse model.
    Cancer Res 2001;61:5242-5247. PM:11431365

  • Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H.
    Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model.
    Ann Oncol 2002;13:1099-1107. PM:12176790

  • Jahnke K, Thiel E, Martus P, Schwartz S, Korfel A.
    Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.
    Ann Hematol. 2006;85(1):45-50. PM:16132909

  • Kantarjian HM, Walters RS, Smith TL, Keating MJ, Barlogie B, McCredie KB.
    Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia.
    Blood 1988;72:1784-1789. PM:3052630

  • Kasamon YL, Jones RJ, Piantadosi S, Ambinder RF, Abrams RA, Borowitz MJ.
    High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
    Biol Blood Marrow Transplant 2005;11:93-100. PM:15682069

  • Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM.
    Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement.
    Blood 1992;79:2432-2437. PM:1373974

  • Kranz BR, Thiel E, Thierfelder S.
    Immunocytochemical identification of meningeal leukemia and lymphoma: poly-L-lysine-coated slides permit multimarker analysis even with minute cerebrospinal fluid cell specimens.
    Blood 1989;73:1942-1950. PM:2713509

  • Magrath IT, Haddy TB, Adde MA.
    Treatment of patients with high grade non-Hodgkin's lymphomas and central nervous system involvement: is radiation an essential component of therapy?
    Leuk Lymphoma 1996;21:99-105. PM:8907276

  • Montoto S, Lister TA.
    Secondary central nervous system lymphoma: risk factors and prophylaxis.
    Hematol Oncol Clin North Am 2005;19:751-763. PM:16083835

  • Montserrat E, Bosch F, Lopez-Guillermo A, Graus F, Terol MJ, Campo El.
    CNS involvement in mantle-cell lymphoma.
    J Clin Oncol 1996;14:941-944. PM:8622043

  • Recht L, Straus DJ, Cirrincione C, Thaler HT, Posner JB.
    Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.
    Am J Med 1988;84:425-435. PM:3348245

  • Rhodes CH, Glantz MJ, Glantz L, Lekos A, Sorenson GD, Honsinger C.
    A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis.
    Cancer 1996;77:543-548. PM:8630963

  • Shahab N, Doll DC.
    Testicular lymphoma.
    Semin Oncol 1999;26:259-269. PM:10375083

  • Storch-Hagenlocher B, Haas J, Vogt-Schaden ME, Bentz M, Hoffmann LA, Biessmann A.
    Molecular analysis of the CDR3 encoding region of the immunoglobulin heavy chain locus in cerebrospinal fluid cells as a diagnostic tool in lymphomatous meningitis.
    Ann Neurol 2000;47:211-217. PM:10665492

  • Surapaneni UR, Cortes JE, Thomas D, O'Brien S, Giles FJ, Koller C.
    Central nervous system relapse in adults with acute lymphoblastic leukemia.
    Cancer 2002;94:773-779. PM:11857312

  • Tilly H, Lepage E, Coiffier B, Blanc M, Herbrecht R, Bosly A.
    Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.
    Blood 2003;102:4284-4289. PM:12920037

  • van Besien K, Ha CS, Murphy S, McLaughlin P, Rodriguez A, Amin K.
    Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
    Blood 1998;91:1178-1184. PM:9454747

  • Williams CD, Pearce R, Taghipour G, Green ES, Philip T, Goldstone AH.
    Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
    J Clin Oncol 1994;12:2415-2422. PM:7964958

  • Zeiser R, Burger JA, Bley TA, Windfuhr-Blum M, Schulte-Monting J, Behringer DM.
    Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis - a single centre experience.
    Br J Haematol 2004;124:762-768. PM:15009064

Die Publikation dieser Rubrik wird gefördert durch:
Aktuelle Berichte vom 58th
ASH Annual Meeting 2016,
San Diego, Kalifornien, USA [Mehr]
2016 ASCO Annual Meeting - aktuelle Berichte. Dieser Service wird gefördert durch: